Health Care Activity – Page 4

AI-Guided Cardiac Ablation Outperforms Standard Treatment for Persistent Atrial Fibrillation

5 months ago talkbio0Tagged Artificial Intelligence, Atrial Fibrillation, Cardiac ablation, Electrophysiology (science), Medical service, Pulmonary veins, TAILORED-AF

Volta Medical, artificial intelligence, cardiac ablation, atrial fibrillation, TAILORED-AF trial, pulmonary vein isolation, electrophysiology

FDA Issues Import Alerts for Two Chinese API Manufacturers Following Failed Inspections

6 months ago talkbio0Tagged alpha 1-antitrypsin, Chengdu, Chinese Language, Dosage Forms, Failed, import alert, innovation, Inspection (procedure), manufacturers, Quality, Science of Chemistry, United States Food and Drug Administration, Wuhu

FDA, import alert, Chinese API manufacturers, failed inspections, quality control, Wuhu Nuowei Chemistry, Chengdu Innovation Pharmaceutical

Hims & Hers Super Bowl Ad Sparks Controversy Over Weight Loss Drug Marketing

6 months ago talkbio0Tagged Consumer Safety, Dosage Forms, Glucagon-Like Peptide 1, Hims & Hers, scrutiny, Super Bowl ad, Telemedicine, United States Food and Drug Administration, Weight-Loss Agents

Hims & Hers, Super Bowl ad, weight loss drugs, FDA scrutiny, compounded GLP-1 drugs, pharmaceutical advertising, telehealth, consumer safety

Pliant Therapeutics Halts Key Fibrosis Drug Trial, Stock Plummets Amid Uncertainty

6 months ago talkbio0Tagged BEACON-IPF, bexotegrast, Clinical Trials, crash, Data Safety, Idiopathic Pulmonary Fibrosis, Pliant, Preventive monitoring

Pliant Therapeutics, bexotegrast, idiopathic pulmonary fibrosis, BEACON-IPF trial, clinical trial pause, stock crash, Data Safety Monitoring Board

Eli Lilly’s Zepbound Surpasses $4.9 Billion in First Year Sales Despite Q4 Shortfall

6 months ago talkbio0Tagged Advice, earnings, Eli, Eli Lilly, Glucagon-Like Peptide 1, Mounjaro, Obesity, pharmaceutical revenue, Zepbound

Eli Lilly, Zepbound, obesity drug, Q4 2024 earnings, pharmaceutical revenue, GLP-1 medications, Mounjaro, 2025 guidance

AstraZeneca Shares Rise as China Investigation Impact Appears Limited

6 months ago talkbio0Tagged AstraZeneca, China, Evaluation, financial performance, import taxes, investor, Prices, Self Confidence

AstraZeneca, China investigation, share price, financial performance, import taxes, investor confidence

LinusBio Introduces ClearStrand-ASD: Revolutionary Autism Diagnostic Aid Using Hair Analysis

6 months ago talkbio0Tagged Autistic Disorder, biomarker test, ClearStrand-ASD, Detection, Diagnosis, Exposome, Hair Analysis, LinusBio, Negative Predictive Value of Diagnostic Test

LinusBio, ClearStrand-ASD, autism diagnostic, hair analysis, biomarker test, early detection, negative predictive value, exposome medicine

U.S. Hospitals Urge Trump to Exempt Medical Supplies and Pharmaceuticals from New Tariffs

6 months ago talkbio0Tagged Canada, chain disruption, China, Health care facility, medical supplies, Mexico, patient safety, tariffs

Tariffs, medical supplies, pharmaceuticals, American Hospital Association, China, Mexico, Canada, healthcare costs, supply chain disruption, patient safety

Pfizer Exceeds Q4 Expectations: COVID-19 Products and Cost-Cutting Drive Strong Performance

6 months ago talkbio0Tagged Advice, cost-cutting initiatives, COVID19 (disease), earnings, financial recovery, Pfizer, portfolio, revenue growth

Pfizer, Q4 earnings, COVID-19 portfolio, cost-cutting initiatives, revenue growth, Paxlovid, financial recovery, 2025 guidance

2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes

6 months ago talkbio0Tagged Administration occupational activities, ambulatory care services, Aortic Valve Insufficiency, deal activity, digital health, expansion, Gene Modification, Health care facility, Pharmaceutical Services, regulatory environment, Transplant Registry Unified Management Program

AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration